Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Burning Rock Biotech Limited

BNR ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Healthcare Facilities & Services ·

USA Micro Cap Analyst: N/A

Last Close

$15.83

▼ -2.62%

Market Cap $166.45M · Vol 8.61K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$166.45M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

63.30

Momentum

Beta

1.46

vs Market

52W High

$41.41

61.78% below

52W Low

$6.87

130.35% above

Volume

8.61K

Avg 13.57K

P/B

2.77

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Burning Rock Biotech Limited (BNR) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BNR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-10.24%

+39.49%

+61.15%

-2.31%

YTD

-21.46%

+71.08%

+68.19%

-90.07%

Financials & Valuation

TTM · Annual

Total Revenue	$77.16M
Net Income	$-7,914,373.00
Revenue Growth (YoY)	-9.28%
Gross Margin	74.67%
Operating Margin	-10.16%
Net Profit Margin	-10.26%
ROE	N/A
ROA · ROIC	-6.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	2.78
P/B	2.77
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	105.18M

Technical Indicators

50-Day SMA	$11.64
200-Day SMA	$17.18
RSI (14)	63.30
Beta	1.46
52-Week High	$41.41
52-Week Low	$6.87

Volume Today	8.61K
Avg Daily Volume (30D)	13.57K
Relative Volume	0.63x
Volatility (10D)	137.35
Volatility (30D)	112.02
Free Float	N/A

Analyst Consensus

N/A

Current Price $15.83

Mean Target N/A

52W Low$6.87 52W High$41.41

Current

Target

$6.87 $41.41

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG00V1JWFQ1

ISINUS12233L2060

CountryChina

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateN/A

TypeStocks

Instrument TypeUNT Unit

Similar Halal Stocks

NTRA Natera, Inc. +3.73% LH Labcorp Holdings Inc. +0.05% RDNT RadNet, Inc. +0.92% LALPATHLAB.NS Dr. Lal PathLabs Ltd -1.69% NEO NeoGenomics, Inc. +3.57%

Company Profile

Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.